Gregory A. Firestone - 23 Feb 2024 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role
Chief Business Officer
Signature
/s/ Megan Smeykal, Attorney-in-fact
Issuer symbol
TELA
Transactions as of
23 Feb 2024
Net transactions value
-$3,394
Form type
4
Filing time
27 Feb 2024, 16:35:13 UTC
Previous filing
23 Feb 2024
Next filing
02 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TELA Common Stock Award $0 +15,000 +41% $0.000000 51,226 23 Feb 2024 Direct F1
transaction TELA Common Stock Tax liability $1,697 -240 -0.47% $7.07 50,986 23 Feb 2024 Direct F2
transaction TELA Common Stock Tax liability $1,697 -240 -0.47% $7.07 50,746 24 Feb 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TELA Stock Option (Right to Buy) Award $0 +20,000 $0.000000 20,000 23 Feb 2024 Common Stock 20,000 $7.07 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 23, 2025, subject to the Reporting Person's continuous service through the applicable vesting dates.
F2 Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.
F3 The option vests 25% on February 23, 2025, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.